Olin Corporation faces heightened downside risk as weakening chemical demand and margin compression fears deepen, with stocks having been trading down by -15.52 percent.
What Traders Need To Know
- Q2 results showed a net loss of $0.12 per share versus a $0.01 loss last year, sharply missing expectations for a $0.10 profit and sending the stock down over 5% after hours.
- Analysts at BMO Capital cut their Olin price target from $30 to $25, citing weak housing and auto demand and broad pressure across commodity chemical names.
- Goldman Sachs lowered its Olin price target from $31 to $24, warning of downside earnings risk from Q3 onward due to weaker-than-expected conflict tailwinds and feedstock constraints.
- Recent EPS of -$0.12 versus the +$0.10 consensus highlights a more than $0.20 swing against expectations, resetting the near-term outlook and raising volatility risk for traders.
Weekly Update Jul 27 – Jul 31, 2026: On Saturday, August 01, 2026 Olin Corporation stock [NYSE: OLN] is trending down by -15.52%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Materials industry expert:
Analyst sentiment – negative
Olin sits in a challenged but not broken competitive position across chlor-alkali, epoxy, and Winchester ammunition. Margins are thin (gross margin 6.4%, EBITDA margin 6.1%) and consolidated profitability negative, with LTM ROE at roughly -10% despite legacy double‑digit ROE history. Revenue is stagnating (five‑year CAGR ~1.5%; three‑year down ~8.5%), and the latest quarter showed a net loss and only $7.9 million of operating cash flow. Leverage is elevated (debt/equity 1.9x, interest cover 2.2x), but liquidity is adequate (current ratio 1.4x).
Technically, OLN is in a clear short‑term downtrend: price faded from the 22.5–23 area into a sharp break toward 18.5, with successive lower highs on the week. The long candle spanning 22.39 down to ~20.2, followed by a close at 18.73, signals heavy selling and likely high volume distribution. The actionable level is $20.50–$21.00: that prior range now acts as strong resistance. Below, immediate support sits near $18.00; a sustained break would invite momentum selling.
Fundamentally and versus Materials/Chemicals peers, Olin now screens as a leveraged, late‑cycle, commodity chemical laggard. Sector bellwethers maintain positive earnings and stronger balance sheets, while OLN just posted a material EPS miss (‑$0.12 vs +$0.10 expected) and negative free cash flow. Recent downgrades and target cuts (BMO to $25, Goldman to $24) reflect structurally weaker earnings power into 2H. I see fair value around $19–$20, with resistance at $21 and support at $17; risk‑reward is unfavorable.
More Breaking News
Quick Financial Overview
Olin Corporation is trading under clear pressure after Q2 earnings. The weekly data show the stock fading from a 22.39 high to an 18.73 close, with the sharpest damage on 2026/07/31 after earnings. Intraday, the 5-minute candle shows a violent flush from 20.48 down to 17.73 before a partial bounce to 18.51, confirming aggressive selling followed by short-covering. For traders, that kind of wide intraday range usually marks a momentum shift and attracts active day and swing strategies.
On the income side, Olin Corporation posted Q2 total revenue of about $1.74B, but still recorded a net loss of $13.3M and diluted EPS of -$0.12. That compares unfavorably with expectations for a $0.10 profit and a smaller loss the prior year. Profitability metrics tell the same story: an EBIT margin of -1.5% and a profit margin of about -2.8% point to a business struggling to convert sizable sales into earnings. EBITDA margin near 6.1% suggests the core operations are thinly profitable before interest and special items.
The balance sheet and cash flows add more caution flags. Revenue over three years has declined roughly 8.5%, even though price-to-sales is low at 0.38, which often draws value-oriented traders. Leverage is high, with total debt-to-equity near 1.9 and interest coverage around 2.2, leaving less room if earnings stay weak. Operating cash flow for the quarter was only $7.9M against capital spending of $29M and dividends of $22.8M, producing negative free cash flow of about $21.1M. A dividend yield around 4.3% looks tempting, but coverage from current cash generation is thin.
Conclusion
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:







Leave a reply